147 related articles for article (PubMed ID: 9865229)
1. Marshfield Clinic, physician networks, and the exercise of monopoly power.
Greenberg W
Health Serv Res; 1998 Dec; 33(5 Pt 2):1461-76. PubMed ID: 9865229
[TBL] [Abstract][Full Text] [Related]
2. The minefield after Marshfield: how to avoid antitrust violations.
Caesar NB
Manag Care; 1995 Aug; 4(8):40-5. PubMed ID: 10145014
[No Abstract] [Full Text] [Related]
3. Revised antitrust guidelines. Forming physician network joint ventures.
Anderson KR
Physician Exec; 1997 Feb; 23(2):24-6. PubMed ID: 10164971
[TBL] [Abstract][Full Text] [Related]
4. Physician-operated networks and the new antitrust guidelines.
Kuttner R
N Engl J Med; 1997 Jan; 336(5):386-91. PubMed ID: 9011808
[No Abstract] [Full Text] [Related]
5. Revised DOJ and FTC policy statements offer more options for physician joint ventures.
Busey RC
Healthc Financ Manage; 1996 Nov; 50(11):79-80, 82. PubMed ID: 10162353
[TBL] [Abstract][Full Text] [Related]
6. Do physicians need relief from antitrust laws?
Trombetta W
Mark Health Serv; 1997; 17(2):45-9. PubMed ID: 10170288
[No Abstract] [Full Text] [Related]
7. Department of Justice and Federal Trade Commission issue further guidance relating to physician network joint ventures.
Becker S
Benders Health Care Law Mon; 1996 Oct; ():3-4. PubMed ID: 10162603
[No Abstract] [Full Text] [Related]
8. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
Hirshfeld E
Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
[TBL] [Abstract][Full Text] [Related]
9. Avoiding antitrust compliance difficulties in mergers and acquisitions.
Bryant LE
Healthc Financ Manage; 1993 Aug; 47(8):48-50, 52, 54-8. PubMed ID: 10145853
[TBL] [Abstract][Full Text] [Related]
10. Docs get their way. Under AMA attack, feds back off antitrust enforcement.
Burda D
Mod Healthc; 1996 Jan; 26(2):40-2, 44-5. PubMed ID: 10153956
[TBL] [Abstract][Full Text] [Related]
11. Establishing physician networks within evolving antitrust guidelines.
Retchin TN; Retchin SM
Clin Perform Qual Health Care; 1997; 5(3):140-5. PubMed ID: 10169186
[TBL] [Abstract][Full Text] [Related]
12. The legal framework for effective competition.
Berenson RA; Hastings DA; Kopit WG
Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
[TBL] [Abstract][Full Text] [Related]
13. FTC weighs easing antitrust rules for provider networks.
Gardner J
Mod Healthc; 1995 Dec; 25(50):24. PubMed ID: 10152958
[No Abstract] [Full Text] [Related]
14. Hospital-physician collaboration and competition: the antitrust connection.
Enders RJ
Healthc Financ Manage; 1986 Apr; 40(4):60-8. PubMed ID: 10275461
[TBL] [Abstract][Full Text] [Related]
15. FTC, Justice ask for clarification in Marshfield case.
Taulbee P
Healthc Syst Strategy Rep; 1995 Oct; 12(21):1-2. PubMed ID: 10184452
[No Abstract] [Full Text] [Related]
16. Antitrust guidelines for joint ventures and networks.
Lauderbaugh RA
Bull Am Coll Surg; 1996 Dec; 81(12):8-11. PubMed ID: 10163166
[No Abstract] [Full Text] [Related]
17. Converting new antitrust guidance into action.
Johnson BA
Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
[TBL] [Abstract][Full Text] [Related]
18. How health networks and HMOs could result in public utility regulation.
Weil T
Hosp Health Serv Adm; 1996; 41(2):266-80. PubMed ID: 10157967
[TBL] [Abstract][Full Text] [Related]
19. Preserving antitrust.
O'Neil-White A; Wilber K
HMO; 1995; 36(3):15-7. PubMed ID: 10166472
[TBL] [Abstract][Full Text] [Related]
20. Government agencies soften stance on what constitutes price fixing.
Ettinger DA; Lasser ML
Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]